EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
1.14.14.29 | 5alpha-androstane-3alpha,17beta-diol + NADPH + O2 |
- |
Homo sapiens |
? + NADP+ + H2O |
- |
? |
1.14.14.29 | 5alpha-androstane-3alpha,17beta-diol + NADPH + O2 |
- |
Mus musculus |
? + NADP+ + H2O |
- |
? |
1.14.14.29 | 5alpha-androstane-3beta,17beta-diol + NADPH + H+ + O2 |
- |
Rattus norvegicus |
5alpha,androstane-3beta,7alpha,17beta-triol + NADP+ + H2O |
- |
? |
1.14.14.29 | 5alpha-androstane-3beta,17beta-diol + NADPH + H+ + O2 |
- |
Homo sapiens |
? |
- |
? |
1.14.14.29 | 5alpha-androstane-3beta,17beta-diol + NADPH + H+ + O2 |
- |
Sus scrofa |
? |
- |
? |
1.14.14.29 | cholest-5-ene-3beta,25-diol + NADPH + H+ + O2 |
- |
Mus musculus |
cholest-5-ene-3beta,7alpha,25-triol + NADP+ + H2O |
- |
? |
1.14.14.29 | cholest-5-ene-3beta,25-diol + NADPH + H+ + O2 |
- |
Homo sapiens |
cholest-5-ene-3beta,7alpha,25-triol + NADP+ + H2O |
- |
? |
1.14.14.29 | cholest-5-ene-3beta,25-diol + NADPH + H+ + O2 |
- |
Rattus norvegicus |
cholest-5-ene-3beta,7alpha,25-triol + NADP+ + H2O |
- |
? |
1.14.14.29 | cholest-5-ene-3beta,25-diol + NADPH + H+ + O2 |
- |
Sus scrofa |
cholest-5-ene-3beta,7alpha,25-triol + NADP+ + H2O |
- |
? |
1.14.14.29 | cholest-5-ene-3beta,25-diol + NADPH + H+ + O2 |
CYP7B1 oxysterol 7alpha-hydroxylase pathway synthesizes 25% to 30% of all bile acids |
Mus musculus |
cholest-5-ene-3beta,7alpha,25-triol + NADP+ + H2O |
- |
? |